M. Bilal Abid/LinkedIn
Oct 15, 2024, 14:07
M. Bilal Abid about development of bispecific antibodies across community practices
M. Bilal Abid posted on LinkedIn:
“My vision on broader development of bispecific antibodies across community practices!”
Muhammad Bilal Abid is a Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center. He has also serves as a Senior Clinical Fellow in Hematology/Oncology at The University of Texas Health Science Center at Houston (UTHealth Houston). His work focuses on scientific research, clinical trials, and the development of protocols related to Investigational New Drug (IND) and New Drug Application (NDA) processes in hematology/oncology and cellular therapy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 18, 2025, 17:21
Aug 18, 2025, 17:13
Aug 18, 2025, 17:04
Aug 18, 2025, 16:37
Aug 18, 2025, 16:33